Estradiol Transdermal System should not be used if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to Estradiol Transdermal System or any of its ingredients, or think you may be pregnant.
Before you take Estradiol Transdermal System, tell your healthcare provider if you have unusual vaginal bleeding, have any other medical conditions, are going to have surgery or will be on bed rest, are breast feeding, and about all of the medicines you take.
Estradiol Transdermal System should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks. You and your healthcare professional should talk regularly about whether you still need treatment with Estradiol Transdermal System.
The most common side effects that may occur with Estradiol Transdermal System are headache, breast tenderness, back and limb pain, common cold, upset stomach, nausea, inflammation of the sinuses and irregular vaginal bleeding or spotting.
These are not all the possible effects of Estradiol Transdermal System. Please read the Patient Information section within the full Prescribing Information before taking Estradiol Transdermal System. For more information, ask your healthcare provider or pharmacist for advice about side effects.
Click here for the full Prescribing Information, including Boxed WARNING.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
MINIVELLE® is a registered trademark of Noven Therapeutics, LLC.
For patient, physician and pharmacist inquiries regarding Estradiol Transdermal System, please contact: Tel: 844-884-6796.